Skip to main content
  • SAPIEN M3 System’s early results are ‘encouraging’ for treatment of mitral regurgitation

    Early experience with the Edwards SAPIEN M3 System, a novel treatment of mitral regurgitation (MR), is “encouraging,” said John Webb, MD, director of interventional cardiology at St. Paul’s Hospital in Vancouver, British Columbia.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details